Literature DB >> 20553251

Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap.

Daniel A Barocas1, David F Penson.   

Abstract

OBJECTIVE: To review the literature on racial variation in the pattern of care (PoC) and quality of care (QoC) for prostate cancer, as there are known racial disparities in the incidence and outcomes of prostate cancer. While there are some biological explanations for these differences, they do not completely explain the variation. Differences in the appropriateness and QoC delivered to men of different racial groups may contribute to disparities in outcome.
METHODS: We searched the USA National Library of Medicine PubMed system for articles pertaining to quality indicators in prostate cancer and racial disparities in QoC for prostate cancer.
RESULTS: While standards for appropriate treatment are not clearly defined, racial variation in the PoC has been reported in several studies, suggesting that African-American men may receive less aggressive treatment. There are validated QoC indicators in prostate cancer, and researchers have begun to evaluate racial variation in adherence to these quality indicators. Further quality comparisons, particularly in structural measures, may need to be performed to fully evaluate differences in QoC.
CONCLUSIONS: There is mounting evidence for racial variation in the PoC and QoC for prostate cancer, which may contribute to observed differences in outcome. While some of the sources of racial variation in quality and outcome have been identified through the development of evidence-based guidelines and validated quality indicators, opportunities exist to identify, study and attempt to resolve other components of the quality gap.

Entities:  

Mesh:

Year:  2010        PMID: 20553251      PMCID: PMC2910169          DOI: 10.1111/j.1464-410X.2010.09467.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  65 in total

1.  Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems.

Authors:  Vincent L Freeman; Ramon Durazo-Arvizu; Ahsan M Arozullah; LaShon C Keys
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

2.  The quality of medical care.

Authors:  A Donabedian
Journal:  Science       Date:  1978-05-26       Impact factor: 47.728

3.  Equity in the distribution of quality of care.

Authors:  L Wyszewianski; A Donabedian
Journal:  Med Care       Date:  1981-12       Impact factor: 2.983

4.  Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).

Authors:  K L Danley; J L Richardson; L Bernstein; B Langholz; R K Ross
Journal:  Cancer Causes Control       Date:  1995-11       Impact factor: 2.506

5.  Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.

Authors:  James A Eastham; Michael W Kattan; Elyn Riedel; Colin B Begg; Thomas M Wheeler; Claudia Gerigk; Mithat Gonen; Victor Reuter; Peter T Scardino
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

6.  Quality-of-care indicators for early-stage prostate cancer.

Authors:  Benjamin A Spencer; Michael Steinberg; Jennifer Malin; John Adams; Mark S Litwin
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

7.  Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

Authors:  L Harlan; O Brawley; F Pommerenke; P Wali; B Kramer
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

8.  Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Authors:  Christopher L Amling; Robert H Riffenburgh; Leon Sun; Judd W Moul; Raymond S Lance; Leo Kusuda; Wade J Sexton; Douglas W Soderdahl; Timothy F Donahue; John P Foley; Andrew K Chung; David G McLeod
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

9.  Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.

Authors:  Paul A Godley; Anna P Schenck; M Ahinee Amamoo; Victor J Schoenbach; Sharon Peacock; Michelle Manning; Michael Symons; James A Talcott
Journal:  J Natl Cancer Inst       Date:  2003-11-19       Impact factor: 13.506

10.  Surgeon volume and operative mortality in the United States.

Authors:  John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

View more
  21 in total

1.  Racial, Socioeconomic, and Geographic Disparities in the Receipt, Timing to Initiation, and Duration of Adjuvant Androgen Deprivation Therapy in Men with Prostate Cancer.

Authors:  Chi Nguyen; David R Lairson; Michael D Swartz; Xianglin L Du
Journal:  J Racial Ethn Health Disparities       Date:  2018-06-29

2.  Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents.

Authors:  Marlene Camacho-Rivera; Samuel L Rice; Sehyun Oh; Manuel Paris; Ezinne Akpara; Justen Molina; Michael Obadina; Shireene Mcmillan; Joshua L Mendez Aracena; Jason Morency; Rosario Costas Muniz; Francesca Gany; Carol L Brown; Jason Gonsky; Joseph R Osborne
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-07       Impact factor: 4.254

3.  Completion of guideline-recommended initial evaluation of atrial fibrillation.

Authors:  Moritz F Sinner; Melissa A Greiner; Xiaojuan Mi; Adrian F Hernandez; Paul N Jensen; Jonathan P Piccini; Soko Setoguchi; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Clin Cardiol       Date:  2012-09-13       Impact factor: 2.882

4.  Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.

Authors:  Jinping Xu; James Janisse; Julie Ruterbusch; Joel Ager; Kendra L Schwartz
Journal:  J Racial Ethn Health Disparities       Date:  2015-05-05

5.  A new approach to understanding racial disparities in prostate cancer treatment.

Authors:  Carolyn J Presley; Ann C Raldow; Laura D Cramer; Pamela R Soulos; Jessica B Long; James B Yu; Danil V Makarov; Cary P Gross
Journal:  J Geriatr Oncol       Date:  2013-01       Impact factor: 3.599

6.  Veridical Causal Inference using Propensity Score Methods for Comparative Effectiveness Research with Medical Claims.

Authors:  Ryan D Ross; Xu Shi; Megan E V Caram; Pheobe A Tsao; Paul Lin; Amy Bohnert; Min Zhang; Bhramar Mukherjee
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-10-20

7.  Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.

Authors:  Daniel A Barocas; Vivien Chen; Matthew Cooperberg; Michael Goodman; John J Graff; Sheldon Greenfield; Ann Hamilton; Karen Hoffman; Sherrie Kaplan; Tatsuki Koyama; Alicia Morgans; Lisa E Paddock; Sharon Phillips; Matthew J Resnick; Antoinette Stroup; Xiao-Cheng Wu; David F Penson
Journal:  J Comp Eff Res       Date:  2013-07       Impact factor: 1.744

8.  Racial and Ethnic Health Disparities in Incarcerated Populations.

Authors:  Meghan E Borysova; Ojmarrh Mitchell; Dawood H Sultan; Arthur R Williams
Journal:  J Health Dispar Res Pract       Date:  2012

9.  Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina.

Authors:  Shellie D Ellis; Bonny Blackard; William R Carpenter; Merle Mishel; Ronald C Chen; Paul A Godley; James L Mohler; Jeannette T Bensen
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

10.  Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Authors:  Robert T Dess; Holly E Hartman; Brandon A Mahal; Payal D Soni; William C Jackson; Matthew R Cooperberg; Christopher L Amling; William J Aronson; Christopher J Kane; Martha K Terris; Zachary S Zumsteg; Santino Butler; Joseph R Osborne; Todd M Morgan; Rohit Mehra; Simpa S Salami; Amar U Kishan; Chenyang Wang; Edward M Schaeffer; Mack Roach; Thomas M Pisansky; William U Shipley; Stephen J Freedland; Howard M Sandler; Susan Halabi; Felix Y Feng; James J Dignam; Paul L Nguyen; Matthew J Schipper; Daniel E Spratt
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.